InvestorsHub Logo
Followers 27
Posts 1204
Boards Moderated 0
Alias Born 09/11/2010

Re: None

Tuesday, 01/22/2013 7:12:59 AM

Tuesday, January 22, 2013 7:12:59 AM

Post# of 97237
TTNP Jan 21 article it's starting as anything opioid addiction help will generate lots of media buzz imo ...

http://www.treatment4addiction.com/blog/addiction/the-potential-of-probuphine/

Enter Probuphine. This is a subdermal implant that is designed to deliver six months of buprenorphine hydrochloride (the active ingredient in Subutex and Suboxone) after one treatment. It is also the first drug of its kind to be developed, and it seems that the FDA has realized the need for effective treatment of addiction, as they have accepted Probuphine as a Priority Review drug and plan to move into action on April 30th, 2013.

Even though this is a novel development, this news gives me hope. Six months pass, the intensity of cravings decrease, withdrawals ease, and life goes on. Even if someone who has this treatment decides to use, he or she won’t be able to feel the effects, and the frustration of that will be discouraging. Best of all, that frustration will be linked to using!

How amazing that is: this drug is meant to provide relief from cravings and maintenance, and it can hopefully cause addicts to see the link between frustration and using! If that clarity aids people in achieving and maintaining sobriety, Probuphine can rightfully be called a “miracle drug” for the 21st century.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.